Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Integrating Online Weight Management With Primary Care Support (PROPS)

9 oktober 2020 bijgewerkt door: Heather J. Baer, Brigham and Women's Hospital

Integrating Online Weight Management With Primary Care Support: Patient-Centered Strategies for Addressing Overweight and Obesity in Primary Care

The goal of this project is to adapt an evidence-based online weight management program and integrate it with population management support from primary care practices. Investigators then will conduct a three-arm, cluster-randomized trial to compare the effectiveness of 1) the combined intervention (online weight management program plus population management support) with 2) the stand-alone online weight management program and with 3) usual care, among overweight and obese primary care patients with type 2 diabetes or hypertension. The specific aims are:

  1. a. To adapt an online weight management program and integrate it with population management support, incorporating input from patients, primary care clinicians, and other stakeholders; afterward, investigators will acquire feedback on the positive and negative aspects of the intervention.

    b. To compare the effectiveness of the combined intervention (online weight management program plus population management support) with the stand-alone online program and with usual care.

    Hypothesis 1: The combined intervention will lead to greater weight loss at 12 months compared with the stand-alone online program and with usual care.

  2. To identify mediators of the combined intervention and the stand-alone online program.

    Hypothesis 2: The effects of the combined intervention and the stand-alone online program on weight loss will be mediated by patients' level of engagement, changes in self-efficacy, and changes in diet and physical activity.

  3. To explore whether the effectiveness of the combined intervention and the stand-alone weight management program varies by patient characteristics.

Hypothesis 3: The interventions will be more effective among patients who are younger, white, and higher socioeconomic status, although the population management strategy may help to reduce these differences.

Studie Overzicht

Gedetailleerde beschrijving

Focus Groups and Key Informant Interviews:

Focus groups will be conducted with 5 to 7 patients at the beginning of the study to obtain their feedback about an online program and the population health management support strategy. To be eligible for the focus groups, patients must have a Brigham and Women's Hospital (BWH) primary care clinician, be between ages 20-70 years old, and have a recent BMI (in the past year) between approximately 27 and 40 kg/m2. They should also be interested in weight management and/or motivated to lose weight.

Phone interviews will be conducted at the end of the study to solicit feedback on the BMIQ program and the population health management intervention. Patients in the PROPS Study who are assigned to the online program or combined intervention arm, reach the 18-month timepoint, and complete the final study survey are eligible and will be invited to participate.

Key Informant Interviews will be conducted at the beginning and the end of the study. To be eligible, the key informants must be clinicians or other staff who provide services to patients at one of the participating BWH primary care practices. There are a total of 165 clinicians in these practices, including staff physicians, residents or fellows, and nurse practitioners or physician assistants. Approximately 7 clinicians at each timepoint will be recruited as key informants and will also be asked to complete electronic surveys during the trial.

After adapting the online weight management program and integrating it with the population management support strategy based on our focus groups and key informant interviews, investigators will conduct a three-arm cluster-randomized trial to compare the effectiveness of the combined intervention (online weight management program plus population management support) with the stand-alone online weight management program and with usual care. This will be a pragmatic clinical trial conducted in approximately 14 BWH primary care practices. To be eligible for the trial, patients must have an upcoming scheduled visit at a BWH primary care practice, BMI between 27 and 39.9 kg/m2 at enrollment, and a diagnosis of type 2 diabetes or hypertension. They also must be between ages 20 and 70 (inclusive) at enrollment, speak English or Spanish, and have access the Internet using a computer, tablet, or smart phone. Finally, patients must be motivated to lose weight. Investigators plan to recruit a total of 840 patients for the study (280 per arm). Patients who enroll in the trial will attend regular primary care visits at their practices and also will complete surveys by e-mail, regular mail, or phone.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

840

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • Massachusetts
      • Boston, Massachusetts, Verenigde Staten, 02115
        • Brigham and Women's Hospital

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

20 jaar tot 70 jaar (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  1. upcoming or recent visit at primary care practice affiliated with Brigham and Women's Hospital
  2. age 20-70
  3. diagnosis of type 2 diabetes and/or hypertension
  4. BMI >= 27 and < 40 kg/m2
  5. motivated to lose weight
  6. valid email address and access the Internet using a computer, tablet, or smartphone
  7. English or Spanish-speaking

Exclusion Criteria:

1. on insulin for treatment of their diabetes 2. MI, stroke, or atherosclerotic cardiovascular disease (ASCVD) procedure in last 6 months 3. Unstable angina 4. Currently pregnant or planning to become pregnant during the study period 5. Currently lactating 5. Has had bariatric surgery or planning to have bariatric surgery 6. >5% weight loss in the last 6 months 7. Severe psychiatric illness or impaired mental status 8. Active or diagnosed history of and/or self-reported history of eating disorders 9. Self-reported average consumption of > 14 alcoholic drinks/week 10. Any serious medical condition that would affect weight loss or for which weight loss is contraindicated, including active cancer (excluding non-melanoma skin cancer) or currently being treated for cancer, end stage renal disease (ESRD) on dialysis, etc.

11. On comfort care measures, hospice, or in nursing home 12. Participating in a contra-indicative research study 13. Use of prescription or over-the-counter weight loss medications or an all-liquid diet program in the last 6 months or currently 14. Any other medical contraindication for weight loss or physical activity, or any other reason that the PCP or their delegate (e.g., LPN or RN) did not deem the patient appropriate for the study

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Onderzoek naar gezondheidsdiensten
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Online Program Only
Patients will use an online weight management program called BMIQ, with minimal additional support.
Patients who are enrolled in one of the two arms using the online weight management program (BMIQ) will complete structured educational sessions, follow specific calorie goals and meal plans, participate in self-monitoring activities (i.e., regular tracking of weight, diet, and physical activity), and interact with other features of the program.
Experimenteel: Combined Intervention
Patients will use an online weight management program called BMIQ, but will also receive additional monitoring and support from a population health manager who works with their primary care practices.
Patients who are enrolled in one of the two arms using the online weight management program (BMIQ) will complete structured educational sessions, follow specific calorie goals and meal plans, participate in self-monitoring activities (i.e., regular tracking of weight, diet, and physical activity), and interact with other features of the program.
Patients will receive weight-related population health management support from their primary care practice; their online weight management program data will be monitored by the population health manager, who will conduct outreach with patients at designated points according to the protocol.
Geen tussenkomst: Usual Care
Patients will continue receiving usual care but will also be mailed some general written information about weight management (very minimal intervention.)

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Change in Body Weight at 12 Months
Tijdsspanne: 12 months after the initial primary care visit
change in body weight from enrollment to 12 months
12 months after the initial primary care visit

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Change in Body Weight at 6 Months
Tijdsspanne: 6 months after the initial primary care visit
change in body weight from enrollment to 6 months
6 months after the initial primary care visit
Change in Body Weight at 18 Months
Tijdsspanne: 18 months after the initial primary care visit
change in body weight from enrollment to 18 months
18 months after the initial primary care visit
Percent Weight Change at 6 Months
Tijdsspanne: 6 months after the initial primary care visit
Percent weight change from enrollment to 6 months
6 months after the initial primary care visit
Percent Weight Change at 12-Months
Tijdsspanne: 12 months after the initial primary care visit
Percent weight change from enrollment to 12 months
12 months after the initial primary care visit
Percent Weight Change at 18-Months
Tijdsspanne: 18 months after the initial primary care visit
Percent weight change from enrollment to 18 months
18 months after the initial primary care visit
Percent of Patients With at Least 5% Weight Loss at 6 Months
Tijdsspanne: 6-months after the initial primary care visit
Percent of Patients With at Least 5% Weight Loss from enrollment to 6 months
6-months after the initial primary care visit
Percent of Patients With at Least 5% Weight Loss at 12-months
Tijdsspanne: 12 months after the initial primary care visit
Percent of Patients with at least 5% weight loss from enrollment to 12 months
12 months after the initial primary care visit
Percent of Patients With at Least 5% Weight Loss at 18 Months
Tijdsspanne: 18-months after the initial primary care visit
Percent of Patients With at least 5% weight loss from enrollment to 18 months
18-months after the initial primary care visit
Changes in Self-efficacy Around Weight Loss at 12 Months
Tijdsspanne: 12 months after initial primary care visit
Changes in self-efficacy around weight loss at 12 months Self-efficacy will be assessed by asking patients to rate their confidence in their ability to lose weight on a scale from 1 ("not at all confident") to 10 ("very confident"). A rank of 1-7 reflects low self-efficacy, while 8-10 reflects high self-efficacy based on Bandura's theory of self-efficacy.
12 months after initial primary care visit
Changes in Systolic Blood Pressure
Tijdsspanne: 12 months after the initial primary care visit
changes in systolic blood pressure (BP) from enrollment to 12 months
12 months after the initial primary care visit
Changes in Diastolic Blood Pressure
Tijdsspanne: 12 months after the initial primary care visit
changes in diastolic blood pressure (BP) from enrollment to 12 months
12 months after the initial primary care visit
Changes in Total Cholesterol
Tijdsspanne: 12 months after the initial primary care visit
changes in total cholesterol from Enrollment to 12 Months
12 months after the initial primary care visit
Changes in HDL Cholesterol
Tijdsspanne: 12 months after the initial primary care visit
changes in HDL cholesterol from Enrollment to 12 Months
12 months after the initial primary care visit
Changes in LDL Cholesterol
Tijdsspanne: 12 months after the initial primary care visit
changes in LDL cholesterol from Enrollment to 12 Months
12 months after the initial primary care visit
Changes in Triglycerides
Tijdsspanne: 12 months after the initial primary care visit
changes in triglycerides from enrollment to 12 months
12 months after the initial primary care visit
Changes in HbA1c Levels
Tijdsspanne: 12 months after the initial primary care visit
changes in Hemoglobin (HbA1c) levels from enrollment to 12 months
12 months after the initial primary care visit
Changes in Weight-related Quality of Life Assessed by the Impact of Weight on Quality of Life (IWQOL)-Lite Questionnaire
Tijdsspanne: 12 months after the initial primary care visit
Weight-related quality of life will be assessed using the Impact of Weight of Quality of Life (IWQOL)-Lite questionnare. The IWQOL-Lite is a brief, 31-item self-report measure that consists of scores on five scales (physical function, self-esteem, sexual life, public distress, and work) and a total score (sum of scale scores). Participants are asked to rate items with respect to the past week, with responses from "never true" to "always true". Total scores range from 0 (worst possible quality of life) to 100 (best possible quality of life).
12 months after the initial primary care visit
Changes in Percentage of Patients Reporting Excellent/Very Good Health Status Assessed by Using a 5-point Scale Questionnaire From the 36-Item Short Form Health Survey(SF-36)
Tijdsspanne: 12 months after the initial primary care visit
Health status will be assessed using 5-point scale response to a single question from the SF-36, "In general, would you say that your health is...(1=Excellent, 2=Very Good, 3=Good, 4=Fair, 5=Poor"). A higher score indicates a worse outcome (5= poor health status).
12 months after the initial primary care visit
Changes in Self-reported Physical Activity
Tijdsspanne: 12 months after the initial primary care visit
changes in self-reported physical activity minutes per week
12 months after the initial primary care visit
Changes in Diet, Specifically Fruits/Vegetables, as Measured by the PrimeScreen Questionnaire
Tijdsspanne: 12 months after the initial primary care visit
changes in diet, specifically fruits/vegetables as measured by the PrimeScreen questionnaire, a brief dietary screening tool.
12 months after the initial primary care visit
Changes in Diet, Specifically Whole Grains, as Measured by the PrimeScreen Questionnaire
Tijdsspanne: 12 months after the initial primary care visit
changes in diet, specifically whole grains as measured by the PrimeScreen questionnaire, a brief dietary screening tool.
12 months after the initial primary care visit
Changes in Diet, Specifically Sugar-sweetened Beverages, as Measured by the PrimeScreen Questionnaire
Tijdsspanne: 12 months after the initial primary care visit
changes in diet, specifically sugar-sweetened beverages as measured by the PrimeScreen questionnaire, a brief dietary screening tool.
12 months after the initial primary care visit
Changes in Diet, Specifically Baked Products, as Measured by the PrimeScreen Questionnaire
Tijdsspanne: 12 months after the initial primary care visit
changes in diet, specifically baked products as measured by the PrimeScreen questionnaire, a brief dietary screening tool.
12 months after the initial primary care visit
Changes in Diet, Specifically Processed Meats, as Measured by the PrimeScreen Questionnaire
Tijdsspanne: 12 months after the initial primary care visit
changes in diet, specifically processed meats as measured by the PrimeScreen questionnaire, a brief dietary screening tool.
12 months after the initial primary care visit
Changes in Diet, Specifically Fried Foods, as Measured by the PrimeScreen Questionnaire
Tijdsspanne: 12 months after the initial primary care visit
changes in diet, specifically fried foods as measured by the PrimeScreen questionnaire, a brief dietary screening tool.
12 months after the initial primary care visit

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Heather Baer, ScD, Brigham and Women's Hospital

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

19 juli 2016

Primaire voltooiing (Werkelijk)

8 november 2018

Studie voltooiing (Werkelijk)

8 mei 2019

Studieregistratiedata

Eerst ingediend

4 januari 2016

Eerst ingediend dat voldeed aan de QC-criteria

13 januari 2016

Eerst geplaatst (Schatting)

15 januari 2016

Updates van studierecords

Laatste update geplaatst (Werkelijk)

5 november 2020

Laatste update ingediend die voldeed aan QC-criteria

9 oktober 2020

Laatst geverifieerd

1 oktober 2020

Meer informatie

Termen gerelateerd aan deze studie

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • 2015P002372

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

Nee

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren